Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
University Hospital, Antwerp
NGM Biopharmaceuticals, Inc
Gilead Sciences
Shenzhen BinDeBio Ltd.
Celldex Therapeutics
Stanford University
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center